Alec P. Vahanian

Q: What Schools Are Affiliated With Alec P. Vahanian

Alec P. Vahanian is affiliated with the following schools: University of Sydney, Baylor College of Medicine, Paris Diderot University

Alec P. Vahanian's AcademicInfluence.com Rankings

Alec P. Vahanian

Medical

#1436

World Rank

#1775

Historical Rank

Cardiology

#111

World Rank

#113

Historical Rank

medical Degrees

Download Badge

Medical

Alec P. Vahanian's Degrees

Doctorate Medicine Université Paris Cité

Why Is Alec P. Vahanian Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Alec P. Vahanian's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

2017 ESC/EACTS Guidelines for the management of valvular heart disease. (2017) (3799)
Guidelines on the management of valvular heart disease (version 2012). (2012) (3651)
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. (2006) (3572)
A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. (2003) (3171)
Universal definition of myocardial infarction. (2015) (2234)
Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). (2012) (1896)
[Guidelines on the management of valvular heart disease]. (2013) (1753)
[2017 ESC/EACTS Guidelines for the management of valvular heart disease]. (2017) (1605)
Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. (2003) (1374)
Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. (2003) (1177)
[Guidelines on the management of valvular heart disease (version 2012). The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)]. (2013) (1177)
Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? (2005) (1134)
Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation (2018) (1045)
2021 ESC/EACTS Guidelines for the management of valvular heart disease. (2021) (993)
What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? (2007) (784)
Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial. (2005) (722)
Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. (1999) (709)
Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. (1999) (680)
THROMBOLYSIS WITH TISSUE PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION: NO ADDITIONAL BENEFIT FROM IMMEDIATE PERCUTANEOUS CORONARY ANGIOPLASTY (1988) (654)
Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. (2004) (653)
Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. (2000) (630)
Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). (2008) (616)
Epidemiology of valvular heart disease in the adult (2011) (557)
Prognostic value of the admission electrocardiogram in acute coronary syndromes. (1999) (540)
Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. (1995) (507)
Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. (2001) (481)
Multimodal assessment of the aortic annulus diameter: implications for transcatheter aortic valve implantation. (2010) (442)
Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European association of cardio-thoracic surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). (2008) (437)
Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. (2007) (437)
Infective endocarditis in Europe: lessons from the Euro heart survey (2003) (431)
Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. (2004) (418)
The complex nature of discordant severe calcified aortic valve disease grading: new insights from combined Doppler echocardiographic and computed tomographic study. (2013) (415)
Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry (2016) (412)
Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence. (2009) (388)
2017 ESC/EACTS Guidelines for the management of valvular heart disease. (2017) (374)
International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina (1998) (351)
Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry study. (2014) (343)
Measurement of aortic valve calcification using multislice computed tomography: correlation with haemodynamic severity of aortic stenosis and clinical implication for patients with low ejection fraction (2010) (343)
Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Societ (2017) (321)
Recommendations for the management of patients after heart valve surgery. (2005) (320)
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study (2001) (318)
Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. (1999) (311)
Results of percutaneous mitral commissurotomy in 200 patients. (1989) (306)
Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. (2009) (306)
Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial. (1996) (300)
Epidemiology of acquired valvular heart disease. (2014) (293)
Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification: Results From the First Multicenter Global Registry. (2016) (256)
Treatment and Clinical Outcomes of Transcatheter Heart Valve Thrombosis (2015) (256)
1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Mitral Annular Calcification. (2018) (252)
Recommendations on the management of the asymptomatic patient with valvular heart disease. (2002) (247)
Late results of percutaneous mitral commissurotomy in a series of 1024 patients. Analysis of late clinical deterioration: frequency, anatomic findings, and predictive factors. (1999) (245)
DOUBLE-BLIND RANDOMISED TRIAL OF INTRAVENOUS TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS PLACEBO IN ACUTE MYOCARDIAL INFARCTION (1985) (231)
Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors. (2005) (228)
TGFB2 loss of function mutations cause familial thoracic aortic aneurysms and acute aortic dissections associated with mild systemic features of the Marfan syndrome (2012) (227)
Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. (1999) (224)
Association Between Transcatheter Aortic Valve Replacement and Subsequent Infective Endocarditis and In-Hospital Death. (2016) (221)
Immediate results of percutaneous mitral commissurotomy. A predictive model on a series of 1514 patients. (1996) (221)
Incidence, predictors, and implications of access site complications with transfemoral transcatheter aortic valve implantation. (2012) (215)
Outcomes After Current Transcatheter Tricuspid Valve Intervention: Mid-Term Results From the International TriValve Registry. (2019) (208)
Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials. (2006) (201)
Valvular heart disease in the community: a European experience. (2007) (198)
Predictive factors of early mortality after transcatheter aortic valve implantation: individual risk assessment using a simple score (2014) (196)
Mitral valve disease—current management and future challenges (2016) (192)
Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death. (2015) (188)
Sex Differences in Aortic Valve Calcification Measured by Multidetector Computed Tomography in Aortic Stenosis (2013) (188)
Transcatheter Therapies for Treating Tricuspid Regurgitation. (2016) (187)
Transcatheter versus medical treatment of symptomatic severe tricuspid regurgitation. (2019) (184)
Aortic dilatation patterns and rates in adults with bicuspid aortic valves: a comparative study with Marfan syndrome and degenerative aortopathy (2013) (182)
Respective Performance of 18F-FDG PET and Radiolabeled Leukocyte Scintigraphy for the Diagnosis of Prosthetic Valve Endocarditis (2014) (181)
PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study. (2010) (178)
Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators. (2000) (174)
A synthetic factor-Xa inhibitor (ORG31540/SR9017A) as an adjunct to fibrinolysis in acute myocardial infarction. The PENTALYSE study. (2001) (171)
The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement? (2015) (168)
Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey. (2019) (166)
Aortic Event Rate in the Marfan Population: A Cohort Study (2012) (166)
Cardioband, a transcatheter surgical-like direct mitral valve annuloplasty system: early results of the feasibility trial. (2016) (163)
A Bicuspid Aortic Valve Imaging Classification for the TAVR Era. (2016) (162)
Infective Endocarditis After Transcatheter Aortic Valve Implantation: Results From a Large Multicenter Registry (2015) (159)
The International Multicenter TriValve Registry: Which Patients Are Undergoing Transcatheter Tricuspid Repair? (2017) (155)
Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry Of Pregnancy And Cardiac disease (ROPAC). (2019) (154)
Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). (2008) (150)
Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention (2003) (150)
A dose-finding study of fondaparinux in patients with non-ST-segment elevation acute coronary syndromes: the Pentasaccharide in Unstable Angina (PENTUA) Study. (2004) (147)
Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction. (2000) (146)
Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage (2019) (144)
[Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation]. (2009) (140)
Transcatheter valve implantation for patients with aortic stenosis (2010) (140)
Mortality Within 24 Hours of Thrombolysis for Myocardial Infarction: The Importance of Early Reperfusion (1994) (139)
Percutaneous repair or medical treatment for secondary mitral regurgitation: outcomes at 2 years (2019) (137)
Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly. (2008) (136)
Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN prosthesis: incidence and impact on outcome. (2010) (135)
Feasibility and outcomes of transcatheter aortic valve implantation in high-risk patients with stenotic bicuspid aortic valves. (2012) (135)
Nomograms for aortic root diameters in children using two-dimensional echocardiography. (2010) (135)
Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Societ (2017) (134)
Prevalence and Impact of Atrial Fibrillation in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: An Analysis From the SOURCE XT Prospective Multicenter Registry. (2016) (134)
Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial. (2002) (134)
Risk stratification of patients with aortic stenosis. (2010) (133)
Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction. (2010) (130)
Anesthesia and perioperative management of patients who undergo transfemoral transcatheter aortic valve implantation: an observational study of general versus local/regional anesthesia in 125 consecutive patients. (2011) (128)
Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation. (2015) (126)
Transcatheter Mitral Annuloplasty in Chronic Functional Mitral Regurgitation: 6-Month Results With the Cardioband Percutaneous Mitral Repair System. (2016) (126)
Cardiovascular Disease Prevention in Clinical Practice (2010) (125)
2021 ESC/EACTS Guidelines for the management of valvular heart disease. (2021) (124)
SOURCE 3 Registry: Design and 30-Day Results of the European Postapproval Registry of the Latest Generation of the SAPIEN 3 Transcatheter Heart Valve. (2017) (123)
One-Year Results From the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) Trial (1996) (122)
Transcatheter mitral valve repair for functional mitral regurgitation using the Cardioband system: 1 year outcomes (2018) (122)
Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the Sapien 3: a comparison with the Sapien XT. (2015) (121)
Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study. (2014) (121)
Unexpected complications of transapical aortic valve implantation. (2009) (120)
Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials. (2003) (116)
Functional results 5 years after successful percutaneous mitral commissurotomy in a series of 528 patients and analysis of predictive factors. (1996) (116)
Percutaneous Approaches to Valvular Disease (2004) (115)
Contemporary results of mitral valve repair for infective endocarditis. (2004) (113)
Transcatheter implantation of the MONARC coronary sinus device for mitral regurgitation: 1-year results from the EVOLUTION phase I study (Clinical Evaluation of the Edwards Lifesciences Percutaneous Mitral Annuloplasty System for the Treatment of Mitral Regurgitation). (2011) (111)
Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome (2016) (111)
Transcatheter valve-in-ring implantation after failure of surgical mitral repair. (2013) (111)
Minimal myocardial damage during coronary intervention is associated with impaired outcome. (1999) (110)
Assessment of the mitral valve area in patients with mitral stenosis by multislice computed tomography. (2006) (109)
First-in-Man Implantation of a Tricuspid Annular Remodeling Device for Functional Tricuspid Regurgitation. (2015) (109)
Open issues in transcatheter aortic valve implantation. Part 1: patient selection and treatment strategy for transcatheter aortic valve implantation. (2014) (108)
Open issues in transcatheter aortic valve implantation. Part 2: procedural issues and outcomes after transcatheter aortic valve implantation. (2014) (106)
European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry. (2015) (103)
Transcatheter Replacement of Failed Bioprosthetic Valves: Large Multicenter Assessment of the Effect of Implantation Depth on Hemodynamics After Aortic Valve-in-Valve (2016) (100)
Impact of coronary artery disease on indications for transcatheter aortic valve implantation and on procedural outcomes. (2011) (98)
Degenerative calcific aortic stenosis: a natural history (2012) (97)
SOURCE 3: 1-year outcomes post-transcatheter aortic valve implantation using the latest generation of the balloon-expandable transcatheter heart valve (2017) (97)
Late Results of Percutaneous Mitral Commissurotomy up to 20 Years: Development and Validation of a Risk Score Predicting Late Functional Results From a Series of 912 Patients (2012) (95)
A clinical risk score of myocardial fibrosis predicts adverse outcomes in aortic stenosis (2015) (89)
Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries. (1997) (88)
Transfemoral implantation of transcatheter heart valves after deterioration of mitral bioprosthesis or previous ring annuloplasty. (2015) (88)
Role of radiolabelled leucocyte scintigraphy in patients with a suspicion of prosthetic valve endocarditis and inconclusive echocardiography. (2013) (86)
Temporal trends in percutaneous mitral commissurotomy over a 15-year period. (2004) (85)
Frequency and prognostic value of cardiac troponin I elevation after coronary stenting. (1999) (82)
Comprehensive evaluation of preoperative patients with aortic valve stenosis: usefulness of cardiac multidetector computed tomography (2007) (81)
Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial (vol 292, pg 696, 2004) (2006) (80)
Usefulness of percutaneous balloon commissurotomy for mitral stenosis during pregnancy. (1994) (80)
Clinical Impact of Baseline Right Bundle Branch Block in Patients Undergoing Transcatheter Aortic Valve Replacement. (2017) (79)
Surgical and interventional management of mitral valve regurgitation: a position statement from the European Society of Cardiology Working Groups on Cardiovascular Surgery and Valvular Heart Disease. (2016) (78)
Comparison of 2-Dimensional, 3-Dimensional, and Surgical Measurements of the Tricuspid Annulus Size: Clinical Implications (2015) (78)
Three-dimensional evaluation of the mitral valve area and commissural opening before and after percutaneous mitral commissurotomy in patients with mitral stenosis. (2006) (77)
Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase Results from GUSTO-III (1999) (75)
Treatment of functional mitral regurgitation in chronic heart failure: can we get a ‘proof of concept’ from the MITRA‐FR and COAPT trials? (2019) (74)
A Cardiac Computed Tomography-Based Score to Categorize Mitral Annular Calcification Severity and Predict Valve Embolization. (2020) (72)
Short‐term results of alcohol septal ablation as a bail‐out strategy to treat severe left ventricular outflow tract obstruction after transcatheter mitral valve replacement in patients with severe mitral annular calcification (2017) (71)
The "ten commandments" for the 2021 ESC/EACTS Guidelines on valvular heart disease. (2021) (71)
Dissection in Marfan syndrome: the importance of the descending aorta. (2011) (70)
Survival Outcomes 1 Year After Reperfusion Therapy With Either Alteplase or Reteplase for Acute Myocardial Infarction: Results From the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III Trial (2000) (70)
Combined antiplatelet therapy with ticlopidine and aspirin. A simplified approach to intracoronary stent management. (1996) (70)
The new ESC/EACTS guidelines on the management of valvular heart disease. (2012) (69)
Effect of continued rt-PA administration on the residual stenosis after initially successful recanalization in acute myocardial infarction--a quantitative coronary angiography study of a randomized trial. (1987) (68)
Transseptal Transcatheter Mitral Valve Replacement Using Balloon-Expandable Transcatheter Heart Valves: A Step-by-Step Approach. (2017) (67)
Immediate and mid-term results of repeat percutaneous mitral commissurotomy for restenosis following earlier percutaneous mitral commissurotomy. (2000) (66)
Transcatheter valve replacement in patients with severe mitral valve disease and annular calcification. (2014) (66)
Mitral regurgitation in patients referred for transcatheter aortic valve implantation using the Edwards Sapien prosthesis: mechanisms and early postprocedural changes. (2012) (66)
Clinical and haemodynamic outcomes of balloon-expandable transcatheter mitral valve implantation: a 7-year experience (2018) (64)
Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials. (2001) (63)
Haemodynamic and anatomic progression of aortic stenosis (2015) (62)
Prognosis of valve replacement for aortic stenosis with or without coexisting coronary heart disease: a comparative study. (1993) (61)
Role of antidiuretic hormone in impaired water excretion of patients with congestive heart failure. (1984) (61)
Implementation of Transcatheter Aortic Valve Replacement in France. (2018) (61)
Anesthesia and perioperative management of patients undergoing transcatheter aortic valve implantation: analysis of 90 consecutive patients with focus on perioperative complications. (2010) (60)
Value of multiplane transesophageal echocardiography in determining aortic valve area in aortic stenosis. (1996) (60)
Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCA. (2003) (59)
Reappraisal of percutaneous aortic balloon valvuloplasty as a preliminary treatment strategy in the transcatheter aortic valve implantation era. (2011) (59)
Infective Endocarditis After Transcatheter Aortic Valve ImplantationCLINICAL PERSPECTIVE (2015) (56)
Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. (2005) (55)
The Virtuous Circle. (2017) (55)
Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker. (2002) (55)
2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease. (2018) (54)
Ten-year results of percutaneous mitral commissurotomy in a series of 1024 patients (1998) (53)
Effect of nadroparin, a low-molecular-weight heparin, on clinical and angiographic restenosis after coronary balloon angioplasty: the FACT study. Fraxiparine Angioplastie Coronaire Transluminale. (1997) (53)
Late results of percutaneous mitral commissurotomy for calcific mitral stenosis. (2000) (53)
Does rheumatic myocarditis really exists? Systematic study with echocardiography and cardiac troponin I blood levels. (2003) (52)
Argatroban and Alteplase in Patients with Acute Myocardial Infarction: The ARGAMI Study (2000) (52)
Relationship between longitudinal strain and symptomatic status in aortic stenosis. (2013) (52)
Contemporary criteria for the selection of patients for percutaneous balloon mitral valvuloplasty (2002) (51)
Plasma atrial natriuretic factor and cyclic GMP in mitral stenosis treated by balloon valvulotomy. Effect of atrial fibrillation. (1988) (51)
Size-adjusted left ventricular outflow tract diameter reference values: a safeguard for the evaluation of the severity of aortic stenosis. (2009) (50)
Agreement between the new EuroSCORE II, the Logistic EuroSCORE and the Society of Thoracic Surgeons score: implications for transcatheter aortic valve implantation. (2014) (50)
Long-term outcome after transcatheter aortic valve implantation (2015) (50)
SOURCE 3 RegistryClinical Perspective (2017) (49)
Discrepancy in guidelines for the prevention of thrombo-embolism in patients with prosthetic heart valves: reply (2007) (48)
Preoperative use and safety of coronary angiography for acute aortic valve infective endocarditis (2010) (47)
Timing of Referral of Patients With Severe Isolated Tricuspid Valve Regurgitation to Surgeons (from a French Nationwide Database). (2018) (46)
One-year follow-up of the ASSENT-2 trial: a double-blind, randomized comparison of single-bolus tenecteplase and front-loaded alteplase in 16,949 patients with ST-elevation acute myocardial infarction. (2003) (46)
Multicenter evaluation of Edwards SAPIEN positioning during transcatheter aortic valve implantation with correlates for device movement during final deployment. (2012) (46)
In vitro evaluation of implantation depth in valve-in-valve using different transcatheter heart valves. (2016) (46)
Reversible Edwards Sapien XT dysfunction due to prosthesis thrombosis presenting as early structural deterioration. (2013) (45)
Early hemodynamic changes versus peak values: what is more useful to predict occurrence of dyspnea during stress echocardiography in patients with asymptomatic mitral stenosis? (2011) (45)
Percutaneous mitral commissurotomy for restenosis after surgical commissurotomy: late efficacy and implications for patient selection. (2000) (45)
Age, outcomes, and treatment effects of fibrinolytic and antithrombotic combinations: findings from Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT)-3 and ASSENT-3 PLUS. (2006) (44)
High plasma antidiuretic hormone in patients with cardiac failure: influence of age. (1982) (44)
Transcatheter aortic valve implantation: selection strategy is crucial for outcome. (2009) (43)
Early assessment by transesophageal echocardiography of left atrial appendage function after percutaneous mitral commissurotomy. (1996) (43)
Prognostic value of B-type natriuretic peptide in elderly patients with aortic valve stenosis: the COFRASA–GENERAC study (2013) (43)
Early Reinfarction After Fibrinolysis: Experience From the Global Utilization of Streptokinase and Tissue Plasminogen Activator (Alteplase) for Occluded Coronary Arteries (GUSTO I) and Global Use of Strategies To Open Occluded Coronary Arteries (GUSTO III) Trials (2001) (42)
Percutaneous suture edge-to-edge repair of the mitral valve. (2009) (42)
Relation of mortality of primary angioplasty during acute myocardial infarction to door-to-Thrombolysis In Myocardial Infarction (TIMI) time (2003) (41)
The MITRA-FR study: design and rationale of a randomised study of percutaneous mitral valve repair compared with optimal medical management alone for severe secondary mitral regurgitation. (2015) (41)
Reinterventions after percutaneous mitral commissurotomy during long-term follow-up, up to 20 years: the role of repeat percutaneous mitral commissurotomy. (2013) (41)
Echocardiographic evaluation of the mitral valve area before and after percutaneous mitral commissurotomy: the pressure half-time method revisited. (2005) (41)
Transcatheter heart valve interventions: where are we? Where are we going? (2019) (40)
Clinical and Therapeutic Profile of Patients Presenting With Acute Coronary Syndromes Who Do Not Have Significant Coronary Artery Disease (2000) (40)
Influence of percutaneous mitral commissurotomy on left atrial spontaneous contrast of mitral stenosis. (1993) (40)
Corrigendum to '2017 ESC/EACTS Guidelines for the management of valvular heart disease' [Eur J Cardiothorac Surg 2017;52:616-664]. (2017) (39)
Prognosis of surgically treated chronic aortic valve disease. Predictive indicators of early postoperative risk and long-term survival, based on 439 cases. (1981) (39)
Immediate and mid-term results of percutaneous mitral commissurotomy. (1991) (39)
Percutaneous transvenous mitral commissurotomy using the Inoue balloon: international experience. (1994) (39)
The effect of left ventricular systolic function on long term survival in mitral and aortic regurgitation. (1995) (38)
Educational needs and application of guidelines in the management of patients with mitral regurgitation. A European mixed-methods study (2018) (38)
Mechanisms and management of TAVR-related complications (2013) (38)
Percutaneous mitral annuloplasty through the coronary sinus: an anatomic point of view. (2008) (38)
Impact of Mitral Regurgitation Severity and Left Ventricular Remodeling on Outcome After Mitraclip Implantation: Results From the Mitra-FR Trial. (2020) (38)
Selection of reperfusion therapy for individual patients with evolving myocardial infarction. (1997) (38)
Thirty-day outcomes in patients at intermediate risk for surgery from the SAPIEN 3 European approval trial. (2016) (37)
Efficacy of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: one-year follow-up results of the Assessment of the Safety of a New Thrombolytic-3 (ASSENT-3) randomized trial in acute myocardial infarction. (2004) (37)
Transseptal transcatheter mitral valve implantation for severely calcified mitral stenosis. (2014) (37)
First-in-man transseptal implantation of a "surgical-like" mitral valve annuloplasty device for functional mitral regurgitation. (2014) (37)
Simple Scoring System to Predict In‐Hospital Mortality After Surgery for Infective Endocarditis (2017) (37)
Transfemoral implantation of an Edwards SAPIEN valve in a tricuspid bioprosthesis without fluoroscopic landmarks. (2012) (36)
Adjudicating paravalvular leaks of transcatheter aortic valves: a critical appraisal. (2016) (36)
Progression of aortic valve stenosis is associated with bone remodelling and secondary hyperparathyroidism in elderly patients--the COFRASA study. (2013) (36)
Small abnormal echos after mitral valve replacement with bileaflet mechanical prostheses: predisposing factors and effect on thromboembolism. (1993) (36)
Tricuspid valve and percutaneous approach: No longer the forgotten valve! (2016) (35)
Early and mid-term outcomes in patients undergoing transcatheter aortic valve implantation after previous coronary artery bypass grafting. (2012) (35)
Prognostic value of the infarct- and non-infarct like patterns and cardiovascular magnetic resonance parameters on long-term outcome of patients after acute myocarditis. (2016) (35)
Sequential assessment of mitral valve area during diastole using colour M-mode flow convergence analysis: new insights into mitral stenosis physiology. (2003) (35)
Acute coronary syndromes in patients with pre-existing moderate to severe valvular disease of the heart: lessons from the Euro-Heart Survey of acute coronary syndromes. (2003) (34)
Benefit of early sustained reperfusion in patients with prior myocardial infarction (the GUSTO-I trial). Global Utilization of Streptokinase and TPA for occluded arteries. (1998) (34)
Severe intraprosthetic regurgitation by immobile leaflet after trans-catheter aortic valve implantation. (2011) (34)
Impact of degree of commissural opening after percutaneous mitral commissurotomy on long-term outcome. (2009) (33)
Value of qualitative angiographic grading in aortic regurgitation. (1987) (33)
Relationship Between Valve Calcification and Long-Term Results of Percutaneous Mitral Commissurotomy for Rheumatic Mitral Stenosis (2014) (33)
Contained aortic root rupture after transcatheter aortic valve implantation. (2010) (32)
Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary Arteries. (1999) (32)
Plasma atrial and brain natriuretic peptides in mitral stenosis treated by valvulotomy. (1994) (32)
Evaluation of mitral stenosis in 2008. (2008) (31)
Valvular Heart Disease 2007 (2012) (31)
Transfemoral tricuspid valve-in-ring implantation using the edwards Sapien XT valve: one-year follow-up. (2015) (31)
Comparison of Hypertension Management After Stroke and Myocardial Infarction: Results From ECLAT1—A French Nationwide Study (2004) (31)
Valvular heart diseases in elderly people (2006) (31)
Recurrent ischemia after thrombolysis: importance of associated clinical findings. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-plasminogen activator] for Occluded Coronary Arteries. (1998) (31)
Bail-Out Alcohol Septal Ablation for Left Ventricular Outflow Tract Obstruction After Transcatheter Mitral Valve Replacement. (2016) (30)
Impact of Massive or Torrential Tricuspid Regurgitation in Patients Undergoing Transcatheter Tricuspid Valve Intervention. (2020) (30)
Ventricular arrhythmias in aortic valve disease before and after aortic valve replacement. (1992) (29)
Comparison of cardiovascular risk factors and drug use in 14544 French patients with a history of myocardial infarction, ischaemic stroke and/or peripheral arterial disease (2004) (29)
Percutaneous mitral commissurotomy. (1992) (29)
Compassionate aortic valve implantation for severe aortic regurgitation. (2010) (28)
Secondary valve regurgitation in patients with heart failure with preserved ejection fraction, heart failure with mid-range ejection fraction, and heart failure with reduced ejection fraction. (2020) (28)
Anatomical features of rheumatic and non-rheumatic mitral stenosis: potential additional value of three-dimensional echocardiography. (2013) (28)
Changing demographics of valvular heart disease and impact on surgical and transcatheter valve therapies (2011) (28)
Long-term Efficacy of Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade vs Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Revascularization (2004) (28)
Usefulness of Late Iodine Enhancement on Spectral CT in Acute Myocarditis. (2017) (27)
Percutaneous mitral commissurotomy in the elderly. (1995) (27)
Usefulness of the right parasternal view and non-imaging continuous-wave Doppler transducer for the evaluation of the severity of aortic stenosis in the modern area. (2009) (27)
Indications for surgery in mitral regurgitation. (1991) (26)
Features of patients with severe mitral stenosis with respect to atrial rhythm. Atrial fibrillation in predominant and tight mitral stenosis. (1992) (26)
Immediate and mid-term results of transfemoral aortic valve implantation using either the Edwards Sapien transcatheter heart valve or the Medtronic CoreValve System in high-risk patients with aortic stenosis. (2010) (26)
Transseptal implantation of a transcatheter heart valve in a mitral annuloplasty ring to treat mitral repair failure. (2011) (25)
Outcomes of TTVI in Patients With Pacemaker or Defibrillator Leads: Data From the TriValve Registry. (2020) (25)
Percutaneous valve procedures: an update. (2008) (25)
Transcatheter aortic valve implantation: could it be done without prior balloon valvuloplasty? (2011) (24)
Echocardiography and indications for surgery. (1995) (24)
"Valve-in-valve" implantation in a patient with stentless bioprosthesis and severe intraprosthetic aortic regurgitation. (2009) (24)
Current Indications for Transcatheter Mitral Valve Replacement Using Transcatheter Aortic Valves: Valve-in-Valve, Valve-in-Ring, and Valve-in-Mitral Annulus Calcification. (2021) (24)
Percutaneous valve procedures: what is the future? (2005) (24)
Detection of 18fluoride sodium accumulation by positron emission tomography in calcified stenotic aortic valves. (2012) (23)
Comparison of semiquantitative and quantitative assessment of severity of aortic regurgitation: clinical implications. (2011) (23)
Comparative assessment of ascending aortic aneurysms in Marfan patients using ECG-gated computerized tomographic angiography versus trans-thoracic echocardiography. (2015) (23)
Transcatheter Aortic Valve Replacement to Treat Pure Aortic Regurgitation on Noncalcified Native Valves. (2016) (23)
Trials and tribulations of noninferiority: the ximelagatran experience. (2006) (23)
The Year in Cardiology 2013: valvular heart disease (focus on catheter-based interventions). (2014) (23)
How to manage patients with severe left ventricular dysfunction and valvular regurgitation. (1996) (23)
Usefulness of left atrial volume versus diameter to assess thromboembolic risk in mitral stenosis. (2010) (23)
Transvenous mitral valve replacement after failure of surgical ring annuloplasty. (2012) (23)
Prognostic Value of Exercise-Stress Echocardiography in Asymptomatic Patients With Aortic Valve Stenosis. (2017) (22)
Radiotherapy-induced mitral stenosis: a three-dimensional perspective. (2010) (22)
First reported human case of native mitral infective endocarditis caused by Streptococcus canis. (2014) (22)
False aneurysm after transapical aortic valve implantation. (2009) (22)
Valve Thrombosis After Transcatheter Mitral Valve Replacement. (2016) (22)
Should asymptomatic or mildly symptomatic aortic regurgitation be operated on? (1986) (22)
What are the differences in presentation of candidates for percutaneous mitral commissurotomy across the world and do they influence the results of the procedure? (2008) (22)
Sex Differences in the Progression of Aortic Stenosis and Prognostic Implication: The COFRASA-GENERAC Study. (2016) (21)
Influence of metabolic syndrome and diabetes on progression of calcific aortic valve stenosis. (2017) (21)
The growing burden of infective endocarditis in the elderly. (2003) (21)
Collaborative Angiographic Patency Trial Of Recombinant Staphylokinase (CAPTORS II). (2002) (21)
Determinants and prognostic value of Galectin-3 in patients with aortic valve stenosis (2016) (21)
Effectiveness of Rescue Percutaneous Balloon Aortic Valvuloplasty in Patients With Severe Aortic Stenosis and Acute Heart Failure. (2017) (20)
Relation of mortality of primary angioplasty during acute myocardial infarction to door-to-Thrombolysis In Myocardial Infarction (TIMI) time. (2003) (20)
Outcomes of transcatheter tricuspid valve intervention by right ventricular function: a multicentre propensity-matched analysis. (2021) (19)
Safety and preliminary efficacy of one month glycoprotein IIb/IIIa inhibition with lefradafiban in patients with acute coronary syndromes without ST-elevation; a phase II study. (2000) (19)
Management of asymptomatic patients with severe non-ischaemic mitral regurgitation. Are practices consistent with guidelines? (2008) (19)
Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-Cardiac Surgery (2010) (19)
Transcatheter aortic valve replacement for patients with heart failure. (2015) (18)
Long-term efficacy of percutaneous mitral commissurotomy for restenosis after previous mitral commissurotomy (2013) (18)
Feasibility of percutaneous mitral commissurotomy in patients with commissural mitral valve calcification. (2013) (18)
Traumatic mitral insufficiency following percutaneous mitral dilation: anatomic lesions and surgical implications. (1992) (18)
Transarterial Medtronic CoreValve System Implantation for Degenerated Surgically Implanted Aortic Prostheses (2011) (17)
Ascending aorta dilatation rates in patients with tricuspid and bicuspid aortic stenosis: the COFRASA/GENERAC study (2018) (17)
Dismal Outcomes and High Societal Burden of Mitral Valve Regurgitation in France in the Recent Era: A Nationwide Perspective (2020) (17)
Successful endovascular stroke rescue with retrieval of an embolized calcium fragment after transcatheter aortic valve replacement. (2014) (17)
Transcatheter aortic valve implantation: our vision of the future. (2012) (16)
"Rescue" abciximab for complicated percutaneous transluminal coronary angioplasty. (1998) (16)
Balloon valvuloplasty (2001) (16)
Early and late outcomes after trans-catheter aortic valve implantation in patients with previous chest radiation (2016) (16)
Screening for abdominal aortic aneurysm in coronary care unit patients with acute myocardial infarction using portable transthoracic echocardiography. (2012) (16)
Patient selection for transcatheter mitral valve implantation: why is it so hard to find patients? (2018) (16)
Ventricular arrhythmias in aortic valve disease before and after surgery. (1992) (16)
Influence of late reopening of the infarct-related artery on left ventricular remodelling after myocardial infarction. IRIS Study Group. (1997) (16)
Actual management of patients with asymptomatic aortic valve disease: how practice fits with guidelines. (2007) (15)
[Evaluation by two-dimensional and doppler echocardiography of the results of percutaneous mitral valvuloplasty]. (1989) (15)
Real-time 3D transoesophageal measurement of the mitral valve area in patients with mitral stenosis. (2011) (15)
The long-term outcome of balloon valvuloplasty for mitral stenosis (2002) (15)
Evaluation of mitral valve area by the proximal isovelocity surface area method in mitral stenosis: could it be simplified? (2007) (15)
Echocardiographic Criteria in Selection of Patients for Percutaneous Mitral Commissurotomy (1999) (15)
An unusual cause of pacemaker-induced severe tricuspid regurgitation. (2008) (15)
Tools & techniques: transcatheter aortic valve implantation: transfemoral approach. (2011) (14)
Transoesophageal echocardiography in the assessment of percutaneous mitral commissurotomy. (1991) (14)
Specifics of technique in percutaneous mitral commissurotomy in a case of dextrocardia and situs inversus with mitral stenosis. (1996) (14)
Multi-modality imaging assessment of native valvular regurgitation: an EACVI and ESC council of valvular heart disease position paper. (2022) (14)
Thromboembolic and haemorrhagic risk in mechanical and biological aortic prostheses. (1984) (14)
EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. (2011) (14)
Contemporary Management of Severe Symptomatic Aortic Stenosis. (2021) (13)
Use of abciximab in interventional cardiology. (1998) (13)
A step forward in the evaluation of transcatheter aortic valve implantation. (2010) (13)
One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. GUSTO-I Investigators. (1996) (13)
Impact of Fetuin-A on progression of calcific aortic valve stenosis - The COFRASA - GENERAC study. (2018) (13)
Effect of Transcatheter Mitral Annuloplasty With the Cardioband Device on 3-Dimensional Geometry of the Mitral Annulus. (2016) (13)
Guidelines on valvular heart disease in clinical practice. (2013) (13)
Characteristics and Outcome of COAPT-Eligible Patients in the MITRA-FR Trial. (2020) (13)
Emergency transseptal transcatheter mitral valve-in-valve implantation. (2013) (12)
Percutaneous Coronary Interventions (PCI) (2010) (12)
Management and Outcome of Patients Admitted with Tricuspid Regurgitation in France. (2020) (12)
High-cholesterol + vitamin D2 regimen: a questionable in-vivo experimental model of aortic valve stenosis. (2009) (12)
'Valve-in-valve' implantation in a patient with degenerated aortic bioprosthesis and severe regurgitation. (2009) (12)
Presentation and outcomes of mitral valve surgery in France in the recent era: a nationwide perspective (2020) (12)
Regurgitant Volume/Left Ventricular End-Diastolic Volume Ratio: Prognostic Value in Patients With Secondary Mitral Regurgitation. (2020) (12)
The MITRA-HR study: design and rationale of a randomised study of MITRACLIP® transcatheter mitral valve repair in patients with severe primary mitral regurgitation eligible for high-risk surgery. (2019) (11)
Transient severe reversible functional mitral regurgitation: a three-dimensional transoesophageal perspective. (2010) (11)
Temporal Trends on Percutaneous Mitral Commissurotomy: 30 Years of Experience (2019) (11)
Mitral leaflet separation index: a new method for the evaluation of the severity of mitral stenosis? Usefulness before and after percutaneous mitral commissurotomy. (2007) (11)
Aortic root dilatation in young patients with cryptogenic stroke and patent foramen ovale. (2012) (11)
Comparison of hospital mortality during ST-segment elevation myocardial infarction in the era of reperfusion therapy in women versus men and in older versus younger patients. (2013) (11)
Treatment of calcified aortic stenosis: surgery or percutaneous transluminal aortic valvuloplasty? (1988) (11)
Transcatheter Aortic Valve Replacement: Current Application and Future Directions (2013) (11)
The impact of the development of transcatheter aortic valve implantation on the management of severe aortic stenosis in high-risk patients: treatment strategies and outcome (2017) (10)
An interdisciplinary debate initiated by the European Society of Cardiology Working Group on Valvular Heart Disease. (2012) (10)
Balloon expandable transcatheter heart valves for native mitral valve disease with severe mitral annular calcification. (2016) (10)
Towards improved risk scores: the quest for the grail continues. (2013) (10)
Brief Report: Coronary Heart Disease: An Unknown Association to Pathological Gambling (2011) (10)
Antithrombotic Management after an Ischemic Stroke in French Primary Care Practice: Results from Three Pooled Cross-Sectional Studies (2005) (10)
[Risk factors management in 5708 ambulatory patients suffering from peripheral vascular disease followed in urban practices]. (2005) (10)
Transfemoral valve-in-ring implantation for a failing mitral homograft in the tricuspid position. (2014) (10)
[Etiologic course of heart valve diseases surgically treated during 20 years in France]. (1992) (10)
Delayed aortic dissection after transcatheter aortic valve implantation. (2013) (10)
Percutaneous valve procedures: Present and future (2005) (10)
Eclipsed mitral regurgitation: an unusual cause of acute heart failure (2017) (9)
Determinants and prognostic value of B-type natriuretic peptide in patients with aortic valve stenosis. (2017) (9)
Suprasternal brachiocephalic approach as an alternative route for transcatheter aortic valve implantation: a single-centre experience. (2017) (9)
Should coronary angiography be performed in all patients who undergo catheterization for valvular heart disease? (1986) (9)
Three-dimensional transoesophageal echocardiography in aortic dissection (2008) (9)
First European Guidelines on the Management of Valvular Heart Disease (2007) (9)
Valve-in-Valve and Valve-in-Ring Transcatheter Mitral Valve Implantation in Young Women Contemplating Pregnancy (2020) (9)
Transcatheter aortic valve implantation. Where are we? (2009) (9)
The year in cardiology 2017: valvular heart disease. (2018) (9)
Presentation, management and outcome of heparin-induced thrombocytopenia after valvular heart surgery. (2016) (8)
Anatomic Characterization of the Aortic Root in Patients With Bicuspid and Tricuspid Aortic Valve Stenosis: Does Fusion of Doppler-Echocardiography and Computed Tomography Resolve Discordant Severity Grading? (2019) (8)
Is tricuspid annuloplasty increasing surgical mortality and morbidity during mitral valve replacement? A single-centre experience. (2017) (8)
Usefulness of Subepicardial Hyperemia on Contrast-Enhanced First-Pass Magnetic Resonance Perfusion Imaging for Diagnosis of Acute Myocarditis. (2016) (8)
Transseptal puncture for structural heart intervention: an old technique with new indications (2017) (8)
Late Displacement After Transcatheter Mitral Valve Replacement for Degenerative Mitral Valve Disease With Massive Annular Calcification. (2016) (8)
Fetal and obstetrical impact of percutaneous balloon mitral commissurotomy during pregnancy. (1994) (8)
Acute coronary syndrome in aortic infective endocarditis. (2008) (8)
[Prevalence and management of patients with a prior history of atherothrombotic disease in primary care in France. Results of the ECLAT1 survey]. (2003) (8)
Thrombolysis with rt-PA in acute myocardial infarction: no additional benefit of immediate PTCA (1988) (8)
Tools and Techniques - Clinical: Embolic protection devices in transcatheter aortic valve implantation. (2015) (8)
Aortic Insufficiency (2005) (8)
Management of radiation-induced valvular heart disease due to Hodgkin's Lymphoma in the modern era. (2018) (7)
Antegrade transseptal coronary angiography: an alternative technique in severe vascular disease. (1998) (7)
Causes and temporal trends in procedural deaths after transcatheter aortic valve implantation. (2017) (7)
Antithrombotic Therapy for Patients with Valvular Heart Disease (2008) (7)
Thrombolytic therapy in Europe: current status. (1996) (7)
Emergencies in valve disease (2008) (7)
Prevalence and Impact of Atrial Fibrillation in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement (7)
Echocardiographic measurement of left atrial volume: Does the method matter? (2015) (7)
Echocardiographic right ventricular function assessment before and after successful percutaneous mitral commissurotomy. (2011) (6)
Trends in aortic valve replacement for aortic stenosis: a French nationwide study. (2021) (6)
'Edge to edge' percutaneous mitral valve repair in mitral regurgitation: it can be done but should it be done? (2010) (6)
Echocardiography in the catheterisation laboratory (2010) (6)
[Percutaneous mitral valvuloplasty]. (1990) (6)
How should I treat prosthetic tricuspid stenosis in an extreme surgical risk patient? (2013) (6)
Lessons from the RE-ALIGN trial. (2014) (6)
RATES OF PARAVALVULAR AORTIC REGURGITATION WITH MDCT NOMINAL AREA OVERSIZING OR UNDERSIZING AFTER TRANSCATHETER HEART VALVE REPLACEMENT WITH THE SAPIEN 3: A COMPARISON WITH THE SAPIEN XT (2014) (6)
Hemodynamic correlates of effective arterial elastance in mitral stenosis before and after balloon valvotomy. (1997) (6)
Diabetes, Pre-diabetes and Cardiovascular Diseases (2010) (6)
Diagnosis of acute myocarditis with dual source cardiac tomography. (2015) (6)
2-Year Follow-Up After Transseptal Transcatheter Mitral Valve Replacement With the Cardiovalve. (2020) (6)
One-Year Outcomes of the TRI-REPAIR Study Assessing Cardioband Tricuspid Valve Reconstruction System for Patients with Functional Tricuspid Regurgitation (2019) (6)
Rheumatic Mitral Valve Disease (2009) (6)
Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries. (1996) (6)
Percutaneous mitral balloon commissurotomy: a useful and necessary treatment for the western population. (2000) (6)
Use of abciximab in interventional cardiology. (1998) (5)
[Feasibility of percutaneous exclusion of the left atrial appendage: results of 11 cases]. (2006) (5)
Combined antiplatelet therapy without anticoagulation after stent implantation; the Ticlopidine Aspirin Stent Evaluation (TASTE) study (1996) (5)
Transcatheter aortic valve implantation: a treatment we are going to need! (2013) (5)
Severe secondary mitral regurgitation and left ventricular dysfunction: a 'deadly combination' against which the fight is not over! (2015) (5)
COMPARISON OF THROMBOLYTIC, FIBRINOLYTIC, AND FIBRINOGENOLYTIC PROPERTIES OF TISSUE PLASMINOGEN ACTIVATOR, STREPTOKINASE, SINGLE‐CHAIN UROKINASE, HIGH MOLECULAR WEIGHT AND LOW MOLECULAR WEIGHT UROKINASE IN HUMAN PLASMA IN VITRO (1988) (5)
Obstructive thrombosis of a bileaflet mitral valve assessed with real-time three-dimensional transoesophageal echocardiography. (2009) (5)
Recurrent Ischemia After Thrombolysis: Importance of Associated Clinical Findings fn1fn1This study was supported by grants from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genentech, South San Francisco, California; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmace (1998) (5)
TCT-714 Transcatheter mitral valve replacement with balloon expandable valves in native mitral valve disease due to severe mitral annular calcification: Results from the first global registry (2015) (5)
The optimal treatment strategy for secondary mitral regurgitation: a subject of ongoing debate. (2019) (5)
[Conservative surgery in the treatment of infectious mitral valve insufficiency]. (1994) (5)
Iatrogenic aortic valve perforation assessed using three-dimensional transoesophageal echocardiography. (2011) (5)
How to do a mitral valvuloplasty. (1997) (5)
Transcatheter aortic valve implantation: a snapshot from the United Kingdom. (2011) (5)
Transfer of the posterior tricuspid leaflet and chordae for mitral valve repair. (1995) (5)
“Guidelines Recommendations on the Treatment of Tricuspid Regurgitation. Where Are We and Where Do We Go With Transcatheter Valve Intervention” (2018) (5)
Sunday, 26 August 2012 (2012) (5)
Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death (2010) (5)
Multiple valve disease - assessment, strategy and intervention. (2015) (5)
Complementarity of stenting and abciximab for percutaneous coronary intervention (1998) (5)
Infective Endocarditis After Bentall Surgery: Usefulness of New Imaging Modalities and Outcomes. (2018) (4)
Suprasternal brachiocephalic approach as an alternative route for transcatheter aortic valve implantation: a single-center experience (2017) (4)
Mitral regurgitation (2016) (4)
Predictors of Left Ventricular Outflow Tract Obstruction After Transcatheter Mitral Valve Replacement in Severe Mitral Annular Calcification: An Analysis of the Transcatheter Mitral Valve Replacement in Mitral Annular Calcification Global Registry (2021) (4)
Mitral valve: repair/clips/cinching/chordae. (2017) (4)
Traumatic rupture of papillary muscle after percutaneous mitral commissurotomy. (1990) (4)
Percutaneous mitral commissurotomy: technique, results, and selection of patients. (2004) (4)
Transcatheter Mitral Valve Replacement: The End of the Beginning? (2019) (4)
Coronary obstruction: a rare but devastating complication during transcatheter aortic valve-in-valve implantation (2018) (4)
Indications and outcome of valvuloplasty (1992) (4)
[Management of patients with valvular disease]. (2009) (4)
Two Year Results With Transcatheter Treatment of Functional Mitral Regurgitation With the MONARC (TM) System In the EVOLUTION I Study (2009) (4)
[Percutaneous mitral commissurotomy during pregnancy]. (1993) (4)
Systematic transoesophageal echocardiography after mitral valve replacement: Rates and determinants of paravalvular regurgitation. (2018) (4)
Percutaneous Patent Foramen Ovale (PFO) closure in young patients with both cryptogenic brain infarction and PFO associated with Atrial Septal Aneurysm (ASA). (2006) (4)
The year in cardiology 2014: valvular heart disease. (2015) (4)
The year in cardiology 2016: valvular heart disease. (2017) (4)
Determinants of regurgitant volume in mitral regurgitation: contrasting effect of similar effective regurgitant orifice area in functional and organic mitral regurgitation. (2012) (4)
Aortic valve calcification using multislice CT (2011) (3)
[Percutaneous mitral valvuloplasty]. (1990) (3)
Impact of participation in randomized trials of reperfusion therapy on the time to reperfusion and hospital mortality in ST-segment elevation myocardial infarction: A single-centre cohort study (2016) (3)
Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey. (2022) (3)
[Percutaneous mitral valvuloplasty in the adult. Apropos of 5 cases]. (1986) (3)
[A pitfall of transseptal catheterisation for percutaneous mitral commissurotomy: interruption of the inferior vena cava with azygos continuation]. (2007) (3)
Acute and delayed hormonal changes in mitral stenosis treated by balloon valvulotomy. (1993) (3)
Late myocardial dysfunction after valve replacement in aortic regurgitation: features and pre-operative markers. (1986) (3)
The year in cardiology 2016: valvular heart disease (2017) (3)
Epicardial adipose tissue volume is associated with left ventricular remodelling in calcific aortic valve stenosis. (2019) (3)
[Subvalvular aortic stenosis in adults. Apropos of 31 cases]. (1984) (3)
Transcatheter Mitral Valve Repair in Patients with Functional Mitral Regurgitation One-Year Outcomes From the Multicenter CE Trial (2017) (3)
[Transcutaneous aortic valve implantation: Anesthetic and perioperative management]. (2011) (3)
[5 years results of percutaneous mitral commissurotomy. Apropos of a series of 606 patients; late results after mitral dilatation]. (1996) (3)
Nitrous oxide inhalation for transoesophageal echocardiography: an alternative to benzodiazepine sedation? (2008) (3)
Valvular heart disease (2018) (3)
Detection of prosthetic valve thrombosis using 111indium platelet imaging. (1990) (3)
[Management of patients after valvular heart surgery. Guidelines of the European Cardiologic Society]. (2006) (3)
Predictors and Clinical Impact of Thrombosis after Transcatheter Mitral Valve Implantation using Balloon-Expandable Bioprostheses. (2020) (3)
Response to Letters Regarding Article, "Infective Endocarditis After Transcatheter Aortic Valve Implantation: Results From a Large Multicenter Registry". (2015) (3)
Understanding risk assessment in cardiac surgery patients. (2010) (3)
Pushing the Boundaries of Transcatheter Mitral Valve Replacement. (2019) (3)
Monday, 27 August 2012 (2012) (3)
Predictors of mitral annulus enlargement? A real-time three-dimensional transesophageal study. (2018) (3)
Images in cardiology: Multiple thrombi in the left atrium. (2005) (3)
Predicting the outcome of degenerative mitral regurgitation: a step forward but still a long way to go! (2018) (3)
Grown Up Congenital Heart Disease (2010) (3)
Perspective on the treatment of functional mitral regurgitation using the Cardioband System. (2019) (2)
Mitral balloon valvuloplasty in adults. (1987) (2)
Anatomical features of acute mitral valve repair dysfunction: Additional value of three-dimensional echocardiography. (2017) (2)
Unmet clinical needs in transcatheter mitral valve interventions in 2014. (2014) (2)
Transcatheter tricuspid intervention: the new challenge of structural valve intervention. (2018) (2)
155 Multimodal Assessment of the Aortic Annulus Diameter. Implications for Transcatheter Aortic Valve Implantation (2010) (2)
Measurement of the aortic annulus diameter using transesophageal echocardiography and multislice computed tomography--are they truly comparable? (2014) (2)
[Intravenous thrombolysis with tissue plasminogen activator (rt-PA) at the prehospital phase of acute myocardial infarction. Apropos of 49 cases]. (1989) (2)
What causes mitral annulus dilatation. A three dimensional study (2017) (2)
Poster session Friday 13 December - PM: 13/12/2013, 14:00-18:00 * Location: Poster area (2013) (2)
IMPACT OF AORTIC VALVE CALCIFICATION MEASURED BY MULTIDETECTOR CT ON THE OUTCOME OF PATIENTS WITH AORTIC STENOSIS (2013) (2)
Follow up of patients with mitral stenosis after successful percutaneous commissurotomy (1988) (2)
Percutaneous mitral commissurotomy: an effective treatment in 'ideal' candidates whatever the approach. (1997) (2)
Corrigendum to: Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey. (2022) (2)
Incorporating patients' preferences into the Heart Team equation. (2020) (2)
Management of patients with heart failure and secondary mitral regurgitation (2020) (2)
Incidence and Severity of Paravalvular Aortic Regurgitation With Multidetector Computed Tomography Nominal Area Oversizing or Undersizing After Transcatheter Heart Valve Replacement With the Sapien 3 A (2017) (2)
Aortic stenosis: prognosis and management: Aortic stenosis (2012) (2)
Congenital Heart Diseases (2012) (2)
[Early transesophageal echocardiography after mitral valve replacement. Significance of minor abnormal signals]. (1994) (2)
[Intracardiac echography]. (2007) (2)
TCT-110 Up to One Year Follow Up Results of Transcatheter Annuloplasty Ring Multicentre Trial (2015) (2)
Fetal and Obstetrical Impact of Percutaneous Balloon Mitral Commissurotomy During Pregnancy (1995) (2)
Echocardiography in the Patient Undergoing Catheter Balloon Mitral Valvuloplasty: Patient Selection, Hemodynamic Results, Complications, and Long-Term Outcome (2007) (2)
REGURGITANT VOLUME AND LEFT VENTRICULAR END-DIASTOLIC VOLUME RATIO: A NEW PROGNOSTIC INDICE IN PATIENTS WITH SECONDARY MITRAL REGURGITATION? (2019) (2)
New perspectives: transcatheter aortic valve implantation in the year 2020. (2015) (2)
How should I treat refractory cardiogenic shock in a patient with chronic biventricular heart failure and mitral regurgitation with difficult valve characteristics? (2016) (2)
Real-time 3 D transoesophageal measurement of the mitral valve area in patients with mitral stenosis (2011) (2)
Feasibility and Exploratory Efficacy Evaluation of the Embrella Embolic Deflector System for the Prevention ofCerebral Emboli in Patients Undergoing Transcatheter Aortic ValveReplacement (2)
Persistent fever in a multicomplicated infective endocarditis. (2012) (2)
163 Aortic Valve Calcification Measured by Multislice Computed Tomography in Aortic Stenosis – Correlation with Hemodynamic Severity and Clinical Implication for Patients with low Ejection Fraction (2010) (2)
[Björk-Shiley-Monostrut prosthesis of the aortic valve. Mid-term development]. (1991) (2)
[Value of transesophageal echocardiography in the follow-up of successful percutaneous mitral valvotomy]. (1994) (2)
Cardiovascular Disease during Pregnancy (2010) (2)
Compendium of Abridged ESC Guidelines 2010 (2010) (2)
Management of radiation-induced valvular heart disease in the modern area (2018) (2)
Unusual presentation of cryolife O'Brien(R) stentless aortic valve bioprosthesis dysfunction mimicking infective endocarditis. (2012) (2)
Training the next generation of cardiovascular leaders in health policy and economics (2017) (2)
201 Bleeding complications of thrombolytic therpy in patients with acute myocardial infarction (M.I.) receiving I.V. infusion of SK or 1 chain rtPA (1988) (2)
Mitral valve repair for anterior leaflet disruption after percutaneous mitral dilation. (1991) (2)
Stentless aortic valve bioprosthesis infective endocarditis: an unusual clinical presentation. (2008) (2)
Contrast echocardiography guidance for alcohol septal ablation of hypertrophic obstructive cardiomyopathy. (2010) (2)
The year in cardiology 2015: valvular heart disease. (2016) (2)
[Predictive factors of coronary lesions in aortic stenosis in adults]. (1988) (2)
Optimization of patent foramen ovale detection by contrast transthoracic echocardiography using harmonic imaging. (2008) (2)
Valvular disease: Implications of the new AHA/ACC valvular disease guidelines (2014) (2)
Isolated Tricuspid Valve Surgery – Early and Midterm Outcome from French Nationwide Database and Local Registry (2017) (2)
How should I treat a severely symptomatic, high-risk female patient with degenerated mitral (Carpentier-Edwards porcine) and aortic (Sorin Mitroflow) bioprostheses? (2015) (2)
Atrial fibrillation following transcatheter aortic valve implantation: do we underestimate its frequency and impact? (2012) (2)
Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in 198 patients (2005) (2)
A multi-perforated man: asymptomatic ruptured sinus of Valsalva aneurysm associated with an atrial and ventricular septal defect. (2006) (2)
Prevalence and Definition of Secondary Mitral Regurgitation (2015) (2)
When Transcatheter Therapy Moves to the "Forgotten Valve". (2015) (2)
[Surgically treated chronic aortic valve insufficiency. Long term results. Surgical indications]. (1978) (2)
Performing optimal transcatheter aortic valve implantation: The need for tailored use of transcatheter valves. (2019) (2)
Peri-procedural tamponade following TAVI: Incidence, predictors and impact on outcome (2019) (2)
The Results of Transcatheter Aortic Valve Replacement Continue to Improve: The Specific Example of a Self-Expandable Transcatheter Heart Valve in a Real-Life Registry. (2017) (1)
Thrombolytic treatment in acute myocardial infarction. (1987) (1)
108: Impact of the method used for aortic annulus measurement on TAVI results - A transesophageal echocardiography and multislice computed tomography comparison (2013) (1)
[Percutaneous transluminal valvuloplasty of the mitral valve]. (1988) (1)
Most unstable angina patients benefit from an aggressive approach to early intervention (1999) (1)
A Bicuspid Aortic Valve Imaging Classi ﬁ cation for the TAVR Era (2016) (1)
When surgery is not an option: is there a clinical need for transcatheter tricuspid valve therapies? (2017) (1)
Complications of percutaneous valve interventions (2006) (1)
Determinants and Prognostic Value of Longitudinal Strain in Asymptomatic Aortic Stenosis and Preserved Left Ventricular Ejection Fraction—The COFRASA/GENERAC Study (2017) (1)
[Infectious endocarditis of valve prostheses. Strategy of the diagnosis. Management]. (1984) (1)
Impact of the method used for aortic annulus measurement on transcatheter aortic valve implantation results – a transesophageal echocardiography and multislice computed tomography comparison (2013) (1)
P6344Relationship between bone remodeling and progression of aortic valve stenosis-The COFRASA-GENERAC study (2017) (1)
P1644Influence of heart rate and systolic blood pressure on progression of calcific aortic valve stenosis - The COFRASA-GENERAC study (2017) (1)
Increased Risk of Left Heart Valve Regurgitation Associated with Benfluorex Use in Patients with Diabetes Mellitus. A Multicentre Study (2014) (1)
[Doppler measurement of transvalvular gradients. Simultaneous Doppler-catheterization recordings on 78 patients]. (1987) (1)
Pregnancy Outcomes in Women With Cardiovascular Disease: Evolving Trends Over 10 Years in the ESC Registry of Pregnancy and Cardiac Disease (ROPAC) (2020) (1)
Aortic valve stenosis management: old strategies and future directions: reply (2008) (1)
Prognostic Value of Combination of Hemodynamic Parameters in Asymptomatic Aortic Valve Stenosis—The COFRASA/GENERAC Study (2017) (1)
P5811Real-life management of mitral regurgitations. Lesson from a European survey (2017) (1)
Valve weight in aortic stenosis: back to the basics. (2016) (1)
P1648Ascending aorta dilatation rates in patients with tricuspid and bicuspid aortic stenosis - the COFRASA/GENERAC study (2017) (1)
Assessment of Mitral Stenosis Using Color M-Mode Flow Convergence Analysis: A Clinical Study (1998) (1)
Percutaneous Valvuloplasty in Cardiogenic Shock (2002) (1)
[Measurement of coronary reserve by high-frequency transthoracic Doppler ultrasonography: indications and results]. (2003) (1)
Disintegration of a stentless valved conduit causing contained rupture of the aortic root. (2010) (1)
[Should mitral valve diseases, without or with few symptoms, be treated surgically?]. (1992) (1)
Atrial natriuretic peptide response to postural changes in patients with left atrial hypertension. (1990) (1)
[Coronary reperfusion in acute myocardial infarction]. (2005) (1)
[Acquired childhood heart diseases in developing countries]. (2011) (1)
[Myocardial infarction and disseminated lupus erythematosus]. (2004) (1)
UP TO ONE-YEAR FOLLOW-UP RESULTS FROM A MULTICENTER TRIAL OF A TRANSFEMORAL SYSTEM FOR MITRAL VALVE RECONSTRUCTION (2016) (1)
Transoesophageal echocardiography: an unusual trigger to Takotsubo cardiomyopathy. (2012) (1)
Results of percutaneous left atrial appendage transcatheter occlusion (PLAATO) in 210 patients (2005) (1)
Oral Abstract session: Demanding measurements: why bother?: Thursday 4 December 2014, 16:30-18:00 * Location: Agora (2014) (1)
LONG-TERM IMPACT OF REPEAT PERCUTANEOUS MITRAL COMMISSUROTOMY ON THE NEED FOR SURGERY IN MITRAL STENOSIS. INSIGHTS FROM A SERIES OF 912 PATIENTS WITH A 20-YEAR FOLLOW-UP (2012) (1)
Abciximab associated thrombocytopenia: evidence for a complex interaction with heparin (1998) (1)
Correlations between echocardiography and cardiovascular magnetic resonance in a patient with midventricular stress cardiomyopathy. (2011) (1)
Chapter 21 Valvular Heart Disease (2009) (1)
Let us preserve the harmonious development of transcatheter aortic valve implantation! (2016) (1)
Cardioprotective Effect of Intracoronary Diltiazem in Myocardial Ischaemia Induced by Percutaneous Transluminal Coronary Angioplasty (1996) (1)
VALVE DISEASE Balloon valvuloplasty (2000) (1)
[Aortic stenosis]. (2005) (1)
Multiple thrombi in the left atrium (2005) (1)
159 Predictive factors of mid-term mortality after transcatheter aortic valve implantation (2011) (1)
Matrix remodeling in human aortic valve disease (2003) (1)
Percutaneous treatment of mitral regurgitation: from feasibility to clinical application? (2011) (1)
Measuring Aortic Valve Annulus Size for Transcatheter Aortic Valve Implantation - 2D or 3D Imaging Techniques? (2011) (1)
Left atrial appendage occlusion to prevent stroke in sub-optimal warfarin candidates: Current results of the European multicenter registry trial (2005) (1)
[Midpoint follow-up results of aortic valve replacement with the Ionescu-Shiley pericardial bioprosthesis. Apropos of 109 patients]. (1986) (1)
Transcatheter valve-in-valve or valve-in-ring mitral valve implantation in young women contemplating pregnancy (2020) (1)
Abstract 4238: Speckle Tracking Echocardiography can Identify the Location of Myocardial Injury in Acute Myocarditis (2008) (1)
Risk factors and outcomes in patients with ventricular septal defects (VSD) complicating acute MI (1996) (1)
Valve thrombosis after transcatheter mitral valve implantation (2021) (1)
Percutaneous aortic valve interventions in heart failure patients. (2015) (1)
Prognostic Value of Peak Exercise Systolic Pulmonary Arterial Pressure in Asymptomatic Primary Mitral Valve Regurgitation. (2021) (1)
Exclusion percutanée de l ’ auricule gauche : perspectives Left atrial appendage percutaneous exclusion : Perspectives (2012) (1)
[Operated aortic stenosis. Evaluation of the long-term prognosis using clinical and hemodynamic parameters in a series of 249 cases]. (1979) (1)
Mid-term results of percutaneous mitral balloon valvotomy. (1999) (1)
0402: Assessment of tricuspid annulus shape and orientation using three-dimensional transesophageal echocardiography (2015) (1)
0093: Early and late outcomes after trans-catheter aortic valve implantation in patients with previous thoracic irradiation (2016) (1)
Echocardiography in Infective Endocarditis (2009) (1)
The European Society of Cardiology Webinars. (2014) (1)
Is Transesophageal Echocardiography Needed before Hospital Discharge in Patients after Bentall Surgery? (2017) (1)
Considerations on the poor discriminatory power of the FRANCE-2 risk score: Authors' reply (2014) (1)
What are patient characteristics leading to contra-indicate surgery in elderly patients with severe, symptomatic, aortic stenosis? (2004) (1)
Patterns of aortic dilatation in patients with bicuspid aortic valves: a comparative study with Marfan and annuloaortic ectasia (2013) (1)
The role of transcatheter mitral valve leaflet approximation for the treatment of secondary mitral regurgitation: current status and future prospects (2021) (1)
[Neutropenia and fever after aorto-coronary bypasses]. (2004) (1)
THE IMPACT OF THE PRESENCE AND EXTENT OF VALVE CALCIFICATION ON LONG–TERM RESULTS OF PERCUTANEOUS MITRAL COMMISSUROTOMY (2013) (1)
Coronary Sinus and Direct Annuloplasty Approaches for Percutaneous Mitral Valve Repair (0)
[Indications for intravenous GPIIb/IIIa receptor inhibitors in acute coronary syndrome without prolonged ST syndrome]. (2001) (0)
The EuroIntervention health check 2019. (2019) (0)
Aortic Stenosis Prevalence and TAVR (2013) (0)
Is valve area always measured in patients with aortic stenosis (2003) (0)
[Echocardiography in the catheterization unit]. (2007) (0)
Chapter 10 Percutaneous valvular interventions (2010) (0)
P1784Dismal outcomes and high societal burden of mitral valve regurgitation in France in the recent era (2019) (0)
[Mid-term results of heart valve replacement with 2 types of pericardial heterograft. Apropos of 208 cases]. (1991) (0)
EFFECT OF TRANSCATHETER MITRAL REPAIR WITH THE CARDIOBAND DEVICE ON 3-DIMENSIONAL GEOMETRY OF THE MITRAL ANNULUS (2016) (0)
Is Immediate Angioplasty Required to Restore Coronary Blood Flow at Rest After Recanalisation with Intravenous Recombinant Tissue-type Plasminogen Activator in Patients with Acute Myocardial Infarction? (1989) (0)
[Percutaneous mitral commissurotomy. Apropos of 130 cases]. (1988) (0)
0428: Ferric iron deposits: cause or consequence of calcifications? (2015) (0)
Ranolazine for Treatment of Angina or Dyspnea in Hypertrophic Cardiomyopathy Patients (RHYME) (2016) (0)
PERCUTANEOUS MITRAL VALVE DIRECT ANNULOPLASTY WITH A “SURGICAL-LIKE” RING: RESULTS FROM MULTICENTRE FIRST-IN-MAN FEASIBILITY TRIAL (2015) (0)
Treatment Decision in Aortic Stenosis—Look at the Valve but Do Not Forget the Ventricle (2023) (0)
Tricuspid regurgitation: frequency, management and outcome among patients with severe left-sided valvular heart disease in Europe. Insights from the ESC-EORP valvular heart disease II survey (2022) (0)
[Relationship between symptoms and hemodynamics in aortic insufficiency (author's transl)]. (1981) (0)
Late results, up to 20 year follow-up, of percutaneous mitral commissurotomy (2013) (0)
Cardiac Pacing and Cardiac Resynchronization Therapy (2010) (0)
EFFECT OF TRANSCATHETER MITRAL REPAIR WITH THE CARDIOBAND DEVICE ON 3-DIMENSIONAL GEOMETRY OF THE MITRAL ANNULUS (2016) (0)
132 Aortic root dilatation in young stroke patients with patent foramen ovale (2011) (0)
in mitral stenosis before and after balloon valvotomy Hemodynamic correlates of effective arterial elastance (2015) (0)
Aortic Valve Calcification Measured by Computed Tomography Predicts Outcome in Aortic Stenosis (2013) (0)
[Infectious endocarditis in patients with heart valve prosthesis]. (1982) (0)
Abstract 17354: Aortic Stenosis in Women vs. Men: Differential Severity to Calcification Load Relationship (2011) (0)
142 Impact of coronary artery disease on management of patients referred for transcatheter aortic valve implantation (2011) (0)
Quadricuspid aortic valve: a case study. (2011) (0)
Left atrial appendage occlusion to prevent stroke in suboptimal warfarin candidates: European Multicenter registry trial (2005) (0)
BLEEDING RISK IN INTRAVENOUS THROMBOLYTIC TREATMENT FOR ACUTE MYOCARDIAL INFARCTION (1987) (0)
0574: Determinants and prognostic value of Galectin-3 in patients with aortic valve stenosis - the COFRASA-GENERAC study (2016) (0)
Aortic valve replacement for aortic stenosis in France – influence of centers' volumes on TAVR adoption rate and outcomes (2022) (0)
901-119 Non-occlusive Prosthetic Thrombosis on Transoesophageal Echocardiography After Mitral Surgery: Evolution with Medical Treatment (1995) (0)
[The MitraClip procedure]. (2014) (0)
30726 month follow up results from the european transcatheter tricuspid valve repair multicenter trial (2018) (0)
Does tricuspid annuloplasty increases surgical mortality and morbidity during mitral valve replacement (2017) (0)
Eclipsed mitral regurgitation: a new entity responsible for acute heart failure in patients with preserved left ventricular ejection fraction (2017) (0)
Percutaneous Edge-to-Edge Mitral Valve Repair for Functional Mitral Regurgitation in a High-Surgical-Risk Patient (2013) (0)
Impact of procedural success on clinical outcome after MitraClip: Results from the MITRA-FR trial. (2022) (0)
Management of valve thrombosis (2006) (0)
Causes and predictors of mortality after transcatheter mitral valve implantation in patients with severe mitral annulus calcification (2021) (0)
[Percutaneous exclusion of the left atrial appendage: perspectives]. (2012) (0)
[Percutaneous approaches to mitral valve disease]. (2015) (0)
0083 : Hyperhemia on the first-pass MRI perfusion for the diagnosis of acute myocarditis (2016) (0)
Transcatheter aortic valve implantation (2016) (0)
What are the predictive performance and limitations of the Euroscore II (2013) (0)
Plasma Atrial Natriuretic Factor and Cyclic GMP in Mitral Stenosis (2005) (0)
Poster session Thursday 12 December - PM: 12/12/2013, 14:00-18:00 * Location: Poster area (2013) (0)
between atrial septum morphology and the presence of a residual shunt after percutaneous device closure of patent foramen acute ischemic in stroke due to (2006) (0)
Non-ST-segment Elevation Acute Coronary Syndromes (2010) (0)
[Coronary reperfusion. Can the myocardium and lives be saved by coronary reperfusion treatment?]. (1987) (0)
Exercise-Induced Severe Mitral Regurgitation in a Patient with Mild Rheumatic Mitral Valve Disease at Rest: a Case Report (2012) (0)
0261 : Prognostic value of the “infarct-like” pattern and cardiovascular magnetic resonance parameters for long-term outcome after an acute myocarditis (2016) (0)
Transcatheter aortic valve implantation in 2012 (2012) (0)
Transesophageal echocardiography, an unusual trigger to Takotsubo cardiomyopathy: A case report (2011) (0)
0320 : Cardiac spectral CT scan to diagnose acute myocarditis: a new imaging technique (2016) (0)
329 Patient selection and learning curve influence the results of transapical aortic valve implantation (2010) (0)
157 Stentless Aortic Valve bioprosthesis Dehiscence – A Possible Infective Endocarditis with Atypical Presentation but Serious Consequences (2010) (0)
[Potential course of lesions of the ascending aorta in dystrophic aortic insufficiency]. (1986) (0)
Chapter 2 Diagnostic catheterization for valvular heart disease (2010) (0)
Stable Angina Pectoris (2010) (0)
[Patent foramen ovale percutaneous closure: indications, techniques and results]. (2007) (0)
[Valve replacement by ball prosthesis. Study of risk factors]. (1976) (0)
Percutaneous left atrial appendage occlusion (PLAATO) for stroke prevention: Experience with 180 patients (2006) (0)
Imaging and percutaneous valve therapy (2007) (0)
Abstract 17839: Transcatheter Annuloplasty Ring Multicentre Trial Report (2015) (0)
P5426Obstructive prosthesis caused by valvular pannus: characteristics and diagnostic strategy, about 71 cases (2017) (0)
Management of Acute Coronary Syndromes (2001) (0)
Unexpected findings in anticoagulation management in patients with valvular heart disease after valve surgery (2003) (0)
115 Relation between global longitudinal strain in patients with aortic stenosis: relation with severity and symptoms (2011) (0)
[Advantages of immediate coronary dilatation after thrombolysis using tissue-type plasminogen activator in acute myocardial infarction. A European Cooperative Group trial]. (1988) (0)
[Role of surgery in the treatment of chronic aortic insufficiency]. (1983) (0)
Percutaneous left atrial appendage exclusion (2013) (0)
Use of abciximab in interventional cardiology : Use of GP IIb/IIIa inhibitors in coronary syndromes: State of the Art (1998) (0)
TCT-652 Incidence, Predictors and Clinical Outcomes of Device Malposition Following Transcatheter Aortic Valve Implantation for Degenerative Bioprosthetic Surgical Valves: Insights from the VIVID Registry. (2016) (0)
1024-77 Comparison of Immediate and Mid-term Results Following Percutaneous Mitral Commissurotomy with the Inoue Stepwise Technique and with the Double-Balloon Technique (1995) (0)
Massive tear of the mitral valve after percutaneous mitral commissurotomy by live 3D transthoracic echocardiography (2006) (0)
[Valvular stenosis: treatment by percutaneous dilatation]. (2000) (0)
Subepicardial hyperemia on contrast-enhanced first-pass magnetic resonance perfusion imaging is useful for the diagnosis of acute myocarditis (2017) (0)
Comparisons of the new EuroSCORE II with the logistic EuroSCORE and the Society of Thoracic Surgeons score – implications for transcatheter aortic valve implantation (2013) (0)
Preoperative atrial fibrillation predicts outcome after valve repair for mitral valve prolapse (2014) (0)
247 Non-invasive assessment of coronary flow velocity pattern after primary coronary stenting for acute anterior myocardial infarction. Relationship with coronary velocity reserve and contractile reserve (2003) (0)
1286Isolated tricuspid valve surgery - Early and midterm outcome from French nationwide database and local registry (2017) (0)
Supraventricular Arrhythmias (SVA) (2010) (0)
Oral session V: New Insights on left ventricular function in aortic stenosis * Friday 10 December 2010, 08:30-10:00 (2010) (0)
The European Heart Academy of the European Society of Cardiology (2017) (0)
Role of Calcium Channel Blockers in Reducing Acute Ischaemia and Preventing Restenosis in PTCA (2012) (0)
165 Clinical use of real time 3D-echocardiography after percutaneous mitral commissurotomy (commissural assessment and valve area measurements) (2005) (0)
[Anticipation of surgical results in calcified aortic stenosis as a function of age]. (1983) (0)
Fragment After Transcatheter Aortic Valve Replacement Successful Endovascular Stroke Rescue With Retrieval of an Embolized Calcium (2014) (0)
Prognostic Value of Brain Natriuretic Peptide in Elderly Patients With Aortic Stenosis (The Cofrasa-Generac Study) (2012) (0)
[Aorto-coronary bridging associated with aortic valve replacement. With reference to 14 cases (author's transl)]. (1975) (0)
[Other indications of thrombolysis: thrombolysis in the elderly, late thrombolysis]. (1992) (0)
[Modern "antiplatelet agents" in unstable angina]. (1996) (0)
Multicentre trial of a transfemoral mitral valve reconstruction system (2017) (0)
Percutaneous mitral valve repair in severe secondary mitral regurgitation: Analysis of index hospitalization and economic evaluation based on the MITRA-FR trial (2021) (0)
Wednesday, 29 August 2012 (2012) (0)
A rare cause of persistent fever in pulmonary homograft endocarditis (2013) (0)
P922Presentation and outcomes of mitral valve surgery in France in the recent era (2019) (0)
CardioPulse: Valvular interventions from the Europeanperspective. (2016) (0)
Chapter 57 Acute valve disease and endocarditis (2010) (0)
Real-time 3D transoesophageal echocardiography evaluation of the mitral valve area in patients with mitral stenosis (2011) (0)
Direct Transcatheter Mitral Valve-in-Ring Replacement to Treat a Failing Alfieri Valve Repair (2023) (0)
P6032Temporal trends on percutaneous mitral commissurotomy: 30 years of experience (2018) (0)
MULTICENTER TRIAL OF A TRANSFEMORAL SYSTEM FOR MITRAL VALVE ANNULOPLASTY: UP-TO-2-YEAR FOLLOW-UP RESULTS (2017) (0)
139 Measurement of the left atrium volume does the method matter (2012) (0)
Preventing cardiac events in unstable angina : New data with diltiazem. Discussion (1996) (0)
145: Role of radiolabeled leukocyte scintigraphy in management of patients with a suspicion of prosthetic valve endocarditis (2013) (0)
478 Relationship between atrial septum morphology and the presence of a residual shunt after percutaneous device closure of patent foramen ovale (2006) (0)
Acute valve disease and endocarditis (2021) (0)
Poster session I * Thursday 9 December 2010, 08:30-12:30 (2010) (0)
Percutaneous Aortic Valve Replacement: Current Status and Future Perspective (2008) (0)
Cost-Benefit of TAVR: Should Indications Be Expanded? (2015) (0)
Percutaneous Approaches to Valvular Disease Review: Clinical Cardiology: New Frontiers (2004) (0)
State-of-the-art nonvascular interventions: mitral valvuloplasty. (2008) (0)
193 Progression of aortic valve stenosis is associated with bone remodeling and secondary hyperparathyroidism (2012) (0)
Full Issue PDF (2020) (0)
Late reopening with angioplasty of totally occluded infarct-related arteries prevents left ventricular remodelling after myocardial infarction (1995) (0)
Aortic prosthetic heart valve obstruction caused by pannus: characteristics and diagnostic strategy, about a 71 patients multicentric study (2017) (0)
33 Valvular heart disease (2011) (0)
Infective endocarditis after Bentall surgery—Usefulness of new imaging modalities and outcome (2017) (0)
Acute and Chronic Heart Failure (2010) (0)
[Traumatic left ventricular aneurysm disclosed by systemic emboli. Value of platelet labelling with indium]. (1984) (0)
New findings with eptifibatide (2000) (0)
[New data on valvular heart diseases]. (2009) (0)
[What's new in cardiology]. (2016) (0)
[Tissue plasminogen activator (t-PA) in myocardial infarction. Biological aspects]. (1986) (0)
Influence of metabolic syndrome on progression of calcific aortic valve stenosis – the COFRASA – GENERAC study (2017) (0)
Echocardiographic findings during percutaneous balloon mitral commissurotomy using the stepwise technique (1996) (0)
USEFULNESS OF AORTIC VALVE CALCIFICATION MEASURED BY COMPUTED TOMOGRAPHY TO PREDICT HEMODYNAMIC PROGRESSION OF AORTIC STENOSIS (2014) (0)
Mitral balloon valvuloplasty (2018) (0)
Transcatheter Edge-to-Edge Repair Gives Years to Life and Life to Years to Elderly Patients With Secondary Mitral Regurgitation. (2022) (0)
TCT-41 Up to two years follow up results of mitral valve transcatheter annuloplasty system for mitral reconstruction multi-center trial. (2016) (0)
141 Assessment of thromboembolic risk in mitral stenosis. Is left atrial volume superior to diameter (2011) (0)
Sudden Cardiac Death and Valvular Heart Diseases (2009) (0)
[Angioplasty of saphenous vein grafts in the acute phase of myocardial infarction. Short and mid-term results]. (2004) (0)
Acute Pulmonary Embolism (2010) (0)
[Unusual development of ventricular aneurysms. Echocardiographic diagnosis]. (1983) (0)
4107Results of Transcatheter Mitral Valve Implantation in Patients with Bioprosthesis Or Annuloplasty Failure Or Mitral Annulus Calcification (2017) (0)
12 Comparative assessment of ascending aortic aneurysms in Marfan patients using CT versus TTE (2015) (0)
314 - Outcomes and prognosis in patient with TGFBR2 or FBN1 gene mutation (2010) (0)
P5443The lack of clinical awareness towards the diagnosis of mitral regurgitation. Insights from a European survey (2017) (0)
endocarditis angiography for acute aortic valve infective Preoperative use and safety of coronary (0)
Two Years' Experience in Transapical Aortic Valve Implantation (2011) (0)
286 Long-term impact of repeat percutaneous mitral commissurotomy on the need for surgery in mitral stenosis. Insights from a series of 912 patients with a 20-year follow-up (2012) (0)
189 Biological study of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction (M.I.) (1988) (0)
[Traumatic tricuspid insufficiency. Apropos of a case treated by conservative surgery]. (1987) (0)
Transcatheter Aortic Valve Implantation: Could It Be Done Without Prior Balloon Valvuloplasty?⁎⁎Editorials published in JACC: Cardiovascular Interventions reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Interventions or the American College of Card (2011) (0)
0026 : Transfemoral tricuspid valve-in-valve and valve-in-ring implantation using the Edwards SAPIEN XT valve: one-year follow-up (2015) (0)
126 Speckle tracking echocardiography as a potential diagnostic method for acute myocarditis: A pilot comparaison to cardiac MRI (2011) (0)
1052 Mitral leaflet separation index: a new method for the evaluation of the severity of mitral stenosis in the setting of percutaneous mitral commissurotomy (2006) (0)
Iconography : Stentless aortic valve bioprosthesis infective endocarditis: an unusual clinical presentation (2008) (0)
The European Heart Academy. (2014) (0)
0007 : Seven-year outcome after TAVI (2016) (0)
Iconographies supplémentaires de l'article : Evaluation of mitral stenosis in 2008 (2017) (0)
Measurement of the aortic annulus diameter using transesophageal echocardiography and multislice computed tomography. Are they interchangeable (2013) (0)
0029 : Is the Euroscore II reliable to estimate operative mortality of valvular surgery? (2013) (0)
1287Early results of a percutaneous tricuspid valve reconstruction system multi center first-in-man feasibility trial (2017) (0)
0374: Seven-year outcome after TAVI (2016) (0)
[Thrombolysis in acute myocardial infarction. Accomplishments and uncertainties in 1992]. (1992) (0)
[Hemorrhagic risk in intravenously administered thrombolytic treatment in acute myocardial infarction]. (1988) (0)
Heart Team Session (2016) (0)
[The CAPITOL study (Captopril Post Infarction Tolerance). A trial of progressive titration of captopril after myocardial infarct with left ventricular dysfunction]. (1999) (0)
Transcatheter mitral valve-in-ring implantation after failed surgical mitral repair : early outcomes (2012) (0)
ASSENT-4 in "French" perspective. Outcomes of STEMI patients treated with pre-hospital thrombolysis in mobile intensive care units in France across trials and registries (2006) (0)
[Valve replacement, a possible factor in myocardial deterioration]. (1984) (0)
Clinical Research Measurement of the Aortic Annulus Diameter Using Transesophageal Echocardiography and Multislice Computed TomographydAre They Truly Comparable (2014) (0)
Transcatheter Aortic Valve Replacement: The Good Results of the New Generation of Transcatheter Aortic Valve Replacement Devices Are Confirmed. (2016) (0)
Transseptal transcatheter mitral valve implantation versus redo surgical mitral valve replacement for degenerated mitral bioprostheses (2020) (0)
Iconographies supplémentaires de l'article : Nomograms for Aortic Root Diameters in Children Using Two-Dimensional Echocardiography (2011) (0)
Management of valve thrombosis : Christa Gohlke-Bärwolf, Alec Vahanian and Eric G Butchart (2006) (0)
Determinants of symptoms in aortic stenosis – Influence of longitudinal strain (2011) (0)
TCT-56 Transcatheter Mitral Valve Repair in Patients with Functional Mitral Regurgitation – One-Year Outcomes from the Multicenter CE Trial (2017) (0)
0407: Evaluation of the tricuspid annulus size: clinical implications from comparison between 2D-transthoracic and 3D-transesophageal echocardiography (2015) (0)
0028 : What are the predictive performance and limitations of the Euroscore II? (2015) (0)
Guidelines on diagnosis and conduct of syncope (version 2009) (2009) (0)
Valvular heart disease: when does surgery remain the best option? (2019) (0)
Percutaneous Mitral Valve Repair: is There a Future? (2008) (0)
Aortic Valve Implantation Transcatheter Valve Implantation for Patients with Aortic Stenosis (2009) (0)
152 - Comparison of semi-quantitative and quantitative assessment of AR severity. Clinical implications. (2011) (0)
Club 35 Poster Session Wednesday 11 December: 11/12/2013, 09:30-16:00 * Location: Poster area (2013) (0)
Chapter 31 – Percutaneous balloon mitral valvuloplasty and mitral valve repair (2008) (0)
Iconography : Persistent fever in a multicomplicated infective endocarditis (2012) (0)
[Valvular heart disease in adults: forward]. (2000) (0)
[Traumatic mitral valve insufficiency after percutaneous mitral valve angioplasty. Mechanisms and surgical technique]. (1991) (0)
[Form a chain of survival for the management of cardiac arrest outside hospital!]. (2005) (0)
Aortic root dilatation in young stroke patients with patent foramen ovale (2011) (0)
INTERVENT IONS FOR STRUCTURAL HEART D ISEASE (2014) (0)
[Prognosis after aortic valve replacement for aortic valve stenosis with or without associated coronary lesions]. (1993) (0)
Outcomes in Diabetic Patients with Acute Myocardial Infarction Impact of Type of Preadmission Sulfonylureas on Mortality and Cardiovascular (2010) (0)
Atrial Fibrillaton (AF) (2010) (0)
Iconography : Causes and temporal trends in procedural deaths after transcatheter aortic valve implantation (2017) (0)
0583: Prognostic significance of longitudinal strain in asymptomatic aortic stenosis and preserved left ventricular ejection fraction – the OFRASA/GENERAC study (2016) (0)
TRANSCATHETER MITRAL VALVE IMPLANTATION IN HIGH-RISK PATIENTS (2016) (0)
Investigation and management of recurrent embolism (2006) (0)
0032: Additional value of exercise-stress echocardiography in asymptomatic patients with aortic valve stenosis (2016) (0)
[Operative mortality and long-term development in aortic valve replacements. Effect of myocardial dysfunction. Apropos of 541 cases]. (1982) (0)
Increased rates of stent thrombosis among patients with acute coronary syndromes: insights from two large oral IIb/IIIa antagonist trials (2001) (0)
Experience With an Innovative New Food and Drug Administration Pathway for First-inHuman Studies Carotid (0)
[Treatment of left ventricular insufficiency with percutaneous trinitrin]. (1980) (0)
Case report Severe intraprosthetic regurgitation by immobile leaflet after trans-catheter aortic valve implantation (2011) (0)
174 Pronostic value of brain natriuretic peptide in elderly patients with aortic stenosis (2012) (0)
117 Real-time 3D transoesophageal echocardiography evaluation of the mitral valve area in patients with mitral stenosis (2011) (0)
3073Up to two-year outcomes from the multicenter CE trial of transcatheter mitral valve repair in patients with functional mitral regurgitation (2018) (0)
ANEVRYSMES VENTRICULAIRES A DEVELOPPEMENT INHABITUEL. DIAGNOSTIC ECHOCARDIOGRAPHIQUE (1983) (0)
Percutaneous left atrial appendage transcatheter occlusion (PLAATO (TM)) to prevent strokes in patients with atrial fibrillation (AF) - Interim Results of the European Registry Trial (2005) (0)
0069 : Early and late outcome after transcatheter aortic valve implantation or surgical aortic valve replacement for high risk patients with aortic stenosis: a monocentric experience (2016) (0)
[Percutaneous mitral commissurotomy]. (1992) (0)
Follow-up after valve surgery (2006) (0)
725-5 Improved Outcome in Patients with Prior Percutaneous Transluminal Coronary Angioplasty and an Evolving Myocardial Infarction (1995) (0)
Use of Cardiac Computed Tomography Prior to Percutaneous Coronary Sinus Device Placement for the Treatment of Mitral Regurgitation Reply (2011) (0)
P2257Peri-procedural tamponade following transcatheter aortic valve implantation: incidence, predictors and impact on outcome (2018) (0)
Current status of percutaneous valvular procedures (2006) (0)
CRT-400.16 Transfemoral System for Mitral Valve Reconstruction - A Multicentre Experience (2016) (0)
08-80 - RESIDUAL SHUNT AFTER PERCUTANEOUS CLOSURE IS RELATED TO PATENT FORAMEN OVALE ANATOMY (2008) (0)
Results of IIb/IIIa receptor blockade in patients with unstable angina. (1999) (0)
Abstract 4377: Euroscore and STS PROM are Not Accurate in Predicting Operative Mortality in Patients Undergoing Transapical Aortic Valve Implantation (2009) (0)
Diagnosis of early dysfunction of a tissue mitral valve replacement by three-dimensional transoesophageal echocardiography. (2010) (0)
Percutaneous mitral valve repair: the beginning of the end or the end of the beginning? (2010) (0)
[Percutaneous valvuloplasty of aortic stenosis in adults. Immediate and mid-term results: apropos of 78 attempts]. (1989) (0)
Unmet needs in valvular heart disease. (2023) (0)
[Mitral stenosis]. (2018) (0)
139: The impact of the presence and extent of valve calcification on long-term results of percutaneous mitral commissurotomy (2013) (0)
Percutaneous valve repairs or when the future of cardiology becomes the present (2014) (0)
Postdischarge and Follow-Up Care (2009) (0)
Poster session V * Saturday 11 December 2010, 08:30-12:30 (2010) (0)
Experts Examine Recent Developments in Interventional Cardiology (2015) (0)
[Indications of coronary angioplasty after thrombolysis]. (1995) (0)
The management of valvular heart disease (2013) (0)
[Positive inotropic agents. Generalities and classification]. (1985) (0)
Commissural prolapse: a marker of severity for mitral valve repair (1998) (0)
014 Impact of type of pre-admission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction (2011) (0)
[Aorto-coronary bridging associated with aortic valve replacement. With reference to 14 cases (author's transl)]. (1975) (0)
229 Screening for abdominal aortic aneurysm among patients admitted for acute myocardial infarction using portable transthoracic echocardiography (2011) (0)
[Hemodynamic evaluation of Ionescu-Shiley pericardial bioprostheses]. (1985) (0)
Heart Team Liege - Session Video Link (2016) (0)
Incidence, clinical impact and treatment outcomes of valve thrombosis after transcatheter mitral valve implantation (2020) (0)
[ASSENT III and GUSTO V: is it the end of combination therapy with GPIIb/IIIa blockers and thrombolytics in myocardial infarction?]. (2002) (0)
The year in cardiology 2017: valvular heart disease (2018) (0)
0079: Respective performances of FDG-PET and radiolabeled leukocyte scintigraphy for the diagnostic of prosthetic valve endocarditis (2015) (0)
The use of cardiac catheterization and coronary angioplasty post myocardial infarction in Europe: observations from the GUSTO I trial (1996) (0)
Compendium of Abridged ESC Guidelines 2011 (2012) (0)
P157What causes mitral annulus dilatation - A three-dimensional transesophageal study (2017) (0)
Recombinant tissue-type plasminogen activator for acute myocardial infarction: must dose be indexed for body weight? (1988) (0)
[Results and indications of coronarography in mitral valvulopathies]. (1985) (0)
The role of matrix metalloproteinases in human cardiac valve diseases (2002) (0)
Screening for abdominal aortic aneurysm among patients admitted for acute myocardial infarction using portable transthoracic echocardiography (2011) (0)
P4716One-year outcomes of the tri-repair study assessing cardioband tricuspid valve reconstruction system for patients with severe tricuspid regurgitation (2019) (0)
Influence of fetunin-A level on progression of calcific aortic valve stenosis – the COFRASA – GENERAC Study (2017) (0)
Vahanian and Palacios Percutaneous Approaches to Valvular Disease 1573 (2004) (0)
Club 35 Poster session 2: Thursday 4 December 2014, 08:30-18:00 * Location: Poster area (2014) (0)
[Percutaneous mitral valvuloplasty: a new treatment of mitral stenosis]. (1987) (0)
155 Percutaneous aortic balloon valvuloplasty as first-line treatment in high-risk patients scheduled for transcatheter aortic valve implantation (2011) (0)
[Results of valvular replacement in chronic or paucisymptomatic aortic insufficiency. Apropos of 79 patients]. (1987) (0)
TRANSFEMORAL TRICUSPID VALVE-IN-VALVE AND VALVE-IN-RING IMPLANTATION USING THE EDWARDS SAPIEN XT VALVE: ONE-YEAR FOLLOW-UP (2016) (0)
SEVEN-YEAR OUTCOME AFTER TAVI (2016) (0)
Guidelines on the identification and treatment of pulmonary hypertension. (2009) (0)
[Aneurysm of the interauricular septum and operated left-right shunt. Echocardiographic aspects]. (1983) (0)
Transfemoral implantation of percutaneous heart valves following atrioventricular bioprosthesis and ring annuloplasty failure (2013) (0)
ESC Education Committee. (2014) (0)
330 Accuracy of surgical scores for prediction of operative mortality in patients undergoing transapical aortic valve implantation (2010) (0)
Imaging Strategies for Coronary Sinus Annuloplasty (2009) (0)
Halte à l'infarctus (2006) (0)
[Indications for percutaneous mitral commissurotomy]. (1995) (0)
FUNCTIONAL IMPROVEMENT ANALYSIS 1 YEAR AFTER PER-CUTANEOUS MITRAL VALVE REPAIR (2016) (0)
Is it possible to perform valve repair for severe mitral regurgitation after percutaneous mitral commissurotomy (1998) (0)
Cryptogenic stroke and PFO diagnosis (2007) (0)
Trends in aortic valve replacement for aortic stenosis: a French nationwide study. (2022) (0)
[Surgical indications and remote results in voluminous aortic insufficiency]. (1978) (0)
160: What are long-term results of percutaneous mitral commissurotomy in patients with few or no symptoms? (2013) (0)
[The risk of hemorrhage versus the thromboembolic risk in patients with prosthetic valve]. (1977) (0)
Long‐Term Results After Percutaneous Balloon Mitral Commissurotomy (2000) (0)
[Clinical characteristics, management and prognostic evolution of patients admitted within six hours of symptom onset with st-segment elevation acute myocardial infarction complicated by cardiogenic shock : twenty year monocentric study]. (2012) (0)
Feasibility of percutaneous mitral commissurotomy in patients with commissural mitral valve calcifications (2013) (0)
AMI in Patients Presenting with Persistent ST-Segment Elevation (2010) (0)
846 Relation between stroke volume changes and hemodynamic response during exercise in patients with severe mitral stenosis and few or no symptoms (2005) (0)
[Percutaneous mitral valvuloplasty]. (1990) (0)
MITRAL valvuloplasty. (1957) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Alec P. Vahanian?

Alec P. Vahanian is affiliated with the following schools: